Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Experimental result published in peer reviewed journal. Some details on methods / results not available

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1992

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Principles of method if other than guideline:
DEP was administered to time-mated rats in the diet during the period of organogenesis and maternal toxicity and effects on embryo-foetal viability, growth and morphogenesis assessed.
GLP compliance:
yes
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Diethyl phthalate
EC Number:
201-550-6
EC Name:
Diethyl phthalate
Cas Number:
84-66-2
Molecular formula:
C12H14O4
IUPAC Name:
.
Details on test material:
- Name of test material (as cited in study report): Dietyl phthalate (DEP)
- Analytical purity: >99%
:

Test animals

Species:
rat
Strain:
Sprague-Dawley
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Laboratories Inc Raleigh NC USA
- Weight at study initiation: females 0gd 207-273 g
- Fasting period before study: No
- Housing: individually in solid bottom polycarbonate cages with stainless steel wire lids (Laboratory products Rochelle Park NJ USA
- Diet (e.g. ad libitum): yes, ground Purina Certified Chow #5002
- Water (e.g. ad libitum): yes, deionised water
- Acclimation period: 7d

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 degrees C
- Humidity (%): 48%
- Photoperiod (hrs dark / hrs light): 12

Administration / exposure

Route of administration:
oral: feed
Vehicle:
other: control feed
Details on exposure:
DIET PREPARATION
- Rate of preparation of diet (frequency):
- Mixing appropriate amounts with (Type of food): mixed with feed in a Patterson Kelley Liquids -Solids twin shell blender
- Storage temperature of food: refridgerated in containers protected from light

VEHICLE
- Justification for use and choice of vehicle (if other than water): control feed, DEP was administered in the diet
- Concentration in vehicle: 0, 0.25, 2.5 & 5.0%
- Lot/batch no. (if required): not reported but fed ground Purina Certified Chow #5002
Analytical verification of doses or concentrations:
yes
Details on analytical verification of doses or concentrations:
Diets were analysed by HPLC before & after use. Analysis confirmed that the diets contained 89-110% of the nominal concentrations.
Details on mating procedure:
- Impregnation procedure: [artificial insemination / purchased timed pregnant / cohoused]: Time mated rats
- If cohoused: bred in pairs
- M/F ratio per cage: 1:1
- Length of cohabitation: overnight until sperm detected in the vagina
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy: sperm in vaginal smear = gd0
Duration of treatment / exposure:
From morning of gd6 to morning of gd15.
Frequency of treatment:
Continuously in the diet
Duration of test:
Until GD 20
Doses / concentrations
Remarks:
Doses / Concentrations:
0, 0.25, 2.5 & 5.0%
Basis:
nominal in diet
No. of animals per sex per dose:
25-32 gravid females
Control animals:
yes, plain diet
Details on study design:
- Dose selection rationale: To include and exceed the range of doses used in earlier study (ip study in 5 animals/group by Singh et al 1972 used 0.57, 1.13 & 1.89 mg/kg during gestation period reported to cause effects onfoetal growth & development including an increase in the incidence of skeletal defects)
- Rationale for animal assignment (if not random): assignment was by stratified randomisation so that body weights were simalar in the groups within each of 2 replicates
- Other: range of 3-4 consecutive breeding days in each replicate. The replicates were 26 days apart

Examinations

Maternal examinations:
CAGE SIDE OBSERVATIONS: No data

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes
- Time schedule for examinations: d: 0, 3, 6, 9, 12, 15, 18, & 20

FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes over 3 day periods from gd6-20 ie gd6-9, 9-12, 12-15, 15-18, 18-20

WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: gd6-9, 9-12, 12-15, 15-18, 18-20

POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day 20
- Organs examined: Not clearly stated

OTHER: Body weight, & liver, kidney and intact uterus weights were recorded. Uteri with no visible implantation sites were stained with 10% amonium sulfide to detect implantation sites from early resorptions.

Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
Fetal examinations:
- External examinations: Yes
- Soft tissue examinations: Yes
- Skeletal examinations: Yes
- Head examinations: Yes
Statistics:
SAS (GLM procedures)software was used for the analysis of variance of maternal & foetal parameters. When ANOVA revealed a significant P<0.05) dose effect Williams & Dunnetts tests were used to compare each treatment group with the concurrent control group. One-tailed were used in the pair wise comparisons except those of body weigt & organ weight. For non significant(p>0.05 dose X replicate effects on foetal parameters data were pooled accross the replicates and non parametric tests applied. When the X2 test indicated significant differences among all groups a one tailed Fisher's exact probability test was used to compare individual treatment groups with the concurrent control group. The alpha level for ball groupwise and pairwise comparisons was 0.05.
Indices:
Not reported
Historical control data:
Not reported

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:yes. Remark: Body weight & body weight gain were reduced in dams given 2.5 and 5% DEP in the diet from on and from 9 respectively. See table below. Food & water consumption was also reduced in these groups during gd 6-9 & 9-12 respectively and increased during in the

Details on maternal toxic effects:
See table below

Effect levels (maternal animals)

open allclose all
Dose descriptor:
NOAEL
Effect level:
0.25 other: %
Based on:
test mat.
Basis for effect level:
other: maternal toxicity
Dose descriptor:
NOAEL
Effect level:
2.5 other: %
Based on:
test mat.
Basis for effect level:
other: developmental toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:yes. Remark: A signicantly increased incidence of variations as a result of the increase in rudimentary extra lumbar ribs in the 5% dose group when compared with the controls. See tables below.

Details on embryotoxic / teratogenic effects:
See tables below

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

Maternal toxicity in CD rats exposed to diethyl phthalate in feed on gestational days 6 to 15

 

Diethyl phthalate (% in feed)

 

0

0.25

2.5

5.0

Subjects (dams)

Total treated

31

32

32

32

Removed

0

11

0

0

No. (%) pregnant

27(87)

29(94)

30(94)

32(100)

Chemical exposure (g/kg/day)2

gd 6 to 9

0

0.21

1.65

1.95

gd 9 to 12

0

0.20

1.97

3.43

gd 12 to 16

0

0.19

2.06

4.39

gd 6 to 16

0

0.20

1.91

3.21

Maternal wt gain (g)3

Gestation period

152.8±4.0

169.2±3.4*

154.8±3.2

145.8±3.9

Treatment period

52.8±2.0

61.4±1.4*

52.6±1.6

30.6±3.2*

Corrected wt gain4

66.4±3.9

78.4±2.4*

67.1±2.7

57.0±3.2*

Gravid uterine wt (g)3

86.0±3.3

90.9±2.6

87.7±2.2

88.7±1.9

Relative food consumption (g/kg/day)2

gd 6 to 9

82.3±1.5

82.3±1.2

65.9±3.7*

39.0±6.1*

gd 9 to 12

78.8±1.1

79.7±2.9

78.6±2.3

68.5±3.9*

gd 12 to 16

76.7±1.2

76.7±1.8

82.5±1.2*

87.7±2.0*

gd 16 to 18

77.9±1.3

79.3±1.3

80.2±1.6

92.2±2.4*

gd 18 to 20

73.2±2.4

73.2±1.6

76.3±2.0

83.0±3.2*

gd 0 to 20

77.9±0.8

77.2±1.0

77.2±0.9

75.6±1.1

Relative water consumption (g/kg/day)2

gd 6 to 9

143.3±4.7

133.5±5.0

121.9±4.1*

119.8±4.9*

gd 9 to 12

143.3±6.0

141.2±4.6

140.8±4.2

154.4±5.6

gd 12 to 16

154.6±14.8

135.0±3.4

150.7±10.8

180.6±8.3

gd 16 to 18

138.8±9.2

138.2±4.8

148.4±4.1

180.6±5.4*

gd 18 to 20

134.6±6.4

126.3±2.4

135.3±3.0

158.0±5.3*

gd 0 to 20

142.1±5.7

133.6±3.4

137.6±3.6

148.9±3.7

1 Dams were removed because of insufficient food or water or for being outside of the weight range

2 Food consumption during treatment (g/day) x % chemical x 1000 mg/g / average body wt during treatment (kg)

3 Includes all dams pregnant at sacrifice, mean±SB

4 Weight gain during gestation minus gravid uterine weight

* Dunnett’s test or Williams’ test, P<0.05             

Linear trend test, P<0.05

Developmental toxicity in CD rats following maternal exposure to diethyl phthalate in feed on gestational days 6 to 15

 

Diethyl phthalate (% feed)

 

0

0.25

2.5

5.0

All litters1

27

29

30

32

No. implant sites/litter

15.2±0.5

15.8±0.4

15.0±0.4

15.5±0.3

% resorptions/litter

3.8±1.4

3.9±0.9

4.1±1.4

3.1±0.7

% litters with resorptions

25.9

48.3

26.7

40.6

Live litters4

27

29

30

32

No. live foetuses/litter

14.6±0.5

15.2±0.5

14.4±0.4

15.0±0.3

% male foetuses/litter

50.4±2.8

48.3±2.8

48.7±2.8

50.2±2.5

Mean body wt. (g)/litter

3.7±0.2

3.9±0.1

3.9±0.1

3.8±0.0

% foetuses malformed/litter

0.7±0.5

0.4±0.3

0.5±0.3

1.3±0.6

% litters with malformed foetuses

7.4

6.9

6.7

15.6

% foetuses with variations/litter

10.6±3.1t

8.4±2.2

12.7±2.8

23.5±4.1*

% litters with variations

51.9+

44.8

66.7

84.4

% foetuses with extra rib/litter

8.8±3.0

7.1±2.0

10.6±2.9

21.0±4.1*

% litters with extra rib

44.4+

39.3

46.7

74.2

1 Includes all dams pregnant at sacrifice litter size = no. implantation sites per dam: mean±SE; 2 One dam had a litter that contained only one dead foetus

3 One dam had 100 resorptions; 4 Includes only dams with live foetuses litter = no. live foetuses per dam: mean±SE

Linear trend test, P<0.05; * Dunnett’s test or Williams’ test, P<0.05; +x2 test, P<0.05;tFisher’s exact test, P<0.05

 

Morphologic defects in CD rat fetuses following maternal exposure to diethyl phthalate in feed on gestational days 6 to 15

 

Diethyl phthalate (% of feed)

 

0

0.25

2.5

5.0

All malformations

Litters with malformations/total litters3

2/27

2/29

2/30

5/32

Malformed foetuses/total examined4

3/394

2/442

2/431

6/479

External malformations

No. litters with defects5

0

1

0

2

No. foetuses with defects6

0

1

0

2

Exencephaly

0

1

0

1

Spina bifida

0

1

0

1

Microphthalmia

0

0

0

1

Visceral malformations

No. litters with defects5

2

0

0

3

No. foetuses with defects6

3

0

0

4

Hydroureter

3

0

0

2

Hydronephrosis

0

0

0

2

Enlarged lateral ventricle of brain

0

0

0

1

Extra renal vessel

0

0

0

1

Skeletal malformations

No. litters with defects5

0

2

2

0

No. foetuses with defects6

0

2

2

0

Fused rib cartilage

0

1

0

0

Short rib XIII

0

1

0

0

Rib cartilage not attached to sternum

0

1

2

0

Variations

No. litters with defects5

14

13

20

27

No. foetuses with defects6

42

38

54

117

Hematoma

3

2

4

2

Open eye

0

0

0

1

Visceral variations

Agenesis of the innominate artery

0

0

0

2

Pale area on liver

0

0

0

1

Distended ureter

3

3

1

3

Skeletal variations

Misaligned sternebra

1

0

2

0

Wavy rib

 

1

1

2

Extra rib (rudimentary)

32

32

44

100

Extra rib (full)

3

0

1

7

Incomplete ossification with cartilage, frontals and/or parietals (midline)

0

0

1

3

Normal cartilage, bipartite ossification centre of vertebral centrum

1

3

0

3

Dumbbell cartilage, bipartite ossification centre of vertebral centrum

0

0

0

0

1 Statistical evaluation of these data is reported in Table 2; 2 Foetuses may have more than one defect; 3 Includes only litters with live foetuses

4 Only live foetuses were examined for defect;5Litters with one or more defective foetuses; 6 Foetuses with one or more defects

 

Applicant's summary and conclusion

Conclusions:
Under the conditions in which this study was performed the NOAELs for maternal & developmental toxicity were 0.25% & 2.5% DEP in the diet due to the reduced maternal body weight at the 2.5 (transient) & 5% dietary concentrations & the increase in the incidence of supernumery ribs in the foetues exposed to 5% DEP in the diet.
Executive summary:

Developmental toxicity has been investigated in the rat using methods similar to those described by OECD test guidelines. Diethyl phthalate was administered in the diet during gestation days 6 -15. The NOAELs for maternal & developmental toxicity were 0.25% (equivalent to 200 mg/kg) and 2.5% (equivalent to 1910 mg/kg) due to the reduced maternal body weight at the 2.5 (transient) & 5% dietary concentrations and an increase in the incidence of supernumery ribs in the foetues exposed to 5% DEP in the diet.